Authors



Joseph T. Dell'Orfano, MD, is with Arrhythmia Consultants of Connecticut, Hartford.

Latest:

Sex differences in atrial fibrillation

IIn their review, Rienstra and Van Gelder summarize their findings from the Rate Control Versus Electrical Cardioversion (RACE) study.


Thomas K. Welty, MD3

Latest:

Prediction of coronary artery disease in patients with diabetes and albuminuria

We developed a set of equations to predict the risk or probability of developing coronary artery disease (CAD) in 10 years among American Indians. The equations are based on the significant risk factors identified in the Strong Heart Study, a longitudinal study of cardiovascular disease in American Indians. The equations can be used in patient education and to evaluate the efficacy of CAD prevention and intervention programs.




Sharon L. Edelstein, ScM

Latest:

Effectiveness and Cost-Effectiveness of Diabetes Prevention among Adherent Participants

Over 10 years, lifestyle intervention and metformin were cost-effective or cost saving compared with placebo.



Sandra Kear

Latest:

Advances in Preventing and Diagnosing Cervical Cancer

Advances in screening and the approval of vaccines against the human papillomavirus (HPV), which causes 70% of cervical cancer cases, have brought us to a turning point with cervical cancer.







Cecilia Pessoa Gingerich

Latest:

Dermatology Care Limited in Rural American Indian Communities

Both brick-and-mortar dermatology clinics as well as telehealth programs are limited and restricted by barriers to access.


Harold L. Lazar, MD, is professor of cardiothoracic surgery, Boston University School of Medicine.

Latest:

Untreated diabetes mellitus in coronary artery by pass graft surgery

Lauruschkat and colleagues entitled their article "Undiagnosed diabetes mellitus in coronary artery bypass graft sur­gery."


Olukayode O. Awosika, MD

Latest:

New-Onset Diabetes and Ketoacidosis in a Patient Treated with Olanzapine

Several case reports published since the introduction of atypical antipsychotics suggest an association between these medications and both new-onset diabetes mellitus and diabetic ketoacidosis. The latter is a potentially life threatening medical emergency. We report the case of a 41-year-old African American woman with schizophrenia who developed type 2 diabetes and ketoacidosis 7 months after commencing olanzapine therapy. This case adds to the evidence in the literature that patients who develop ketoacidosis while taking antipsychotic medications tend to be female and relatively young, a disproportionate number of whom are African American. The frequency of these reports suggests that clinicians should monitor serum glucose levels periodically in all patients treated with atypical antipsychotics, particularly in those at increased risk for diabetes.



University of California TV

Latest:

Life in the Balance: Perspectives on Stem Cell Research

David Gollaher, president and CEO of California Healthcare Institute, discusses the tensions between stem cell research, ethics, and politics.


Adrian C. Borges, MD

Latest:

Analysis of regional left ventricular function

We performed cineventriculography, unenhanced echocardiography, contrast-enhanced echocardiography, and magnetic resonance imaging to define the presence of regional left ventricular wall motion abnormalities. Interobserver agreement in the analysis of regional wall motion abnormality was highest for contrast-enhanced echocardiography, followed by cineventriculography and cardiac magnetic resonance imaging; it was lowest for unenhanced echocardiography. Contrast-enhanced echocardiography also showed the highest accuracy in the detection of panel-defined regional wall motion abnormalities.


P. Michael Ho, MD, PhD1,2 ? John S. Rumsfeld, MD, PhD1,2 ? Frederick A. Masoudi, MD, MSPH2,3,4 ? David L. McClure, PhD, MSc5 ? Mary E. Plomondon, PhD, MSPH1 ? John F. Steiner, MD2,4 ? David J. Magid,

Latest:

Effect of medication nonadherence in diabetes mellitus

We evaluated the association between medication nonadherence and outcomes among subjects with diabetes mellitus. Nonadherent subjects had higher blood pressure, glycosylated hemoglobin, and low-density lipoprotein cholesterol levels. In addition, there was an association between medication nonadherence and an increased risk of all-cause hospitalization and all-cause mortality. These findings suggest that interventions are needed to increase medication adherence so that patients can realize the full benefit of prescribed therapies.


Michael Blumenfield, MD

Latest:

We're Not Providers for Consumers/Clients

What has happened to make receiving health care like buying a car?


Timothy R. Jennings, MD

Latest:

Protecting from Alzheimer in the Female Brain

The fact that nearly 7 of every 10 Alzheimer diagnoses are made in women is not just associated with longer age expectancy.









© 2024 MJH Life Sciences

All rights reserved.